首页> 外国专利> procedure for the detection of apoptosis by determining cytochrome c as apoptosespezifischem markers of cellular ausschu00fcttungsvorgu00e4nge into the extracellular medium is made

procedure for the detection of apoptosis by determining cytochrome c as apoptosespezifischem markers of cellular ausschu00fcttungsvorgu00e4nge into the extracellular medium is made

机译:通过确定细胞色素c作为细胞凋亡的特异性标志物的程序来检测凋亡,该细胞标记物是将细胞听觉进入细胞外培养基中的

摘要

A method for the detection of apoptosis by determining presence, amount, or activity of apoptosis-specific markers released from at least one cell undergoing apoptosis into an extracellular medium through cellular release mechanisms is disclosed. The extracellular medium includes body fluids, in particular urine, inflammatory fluid, serum, liquor, or cell culture medium, wherein samples are preferably taken from humans or animals. The method can be used for the diagnosis and/or for therapy control of diseases and/or processes associated with increased apoptosis. It can also be used for therapy control of diseases associated with decreased apoptosis. Additionally, a method is disclosed for the identification of apoptosis-modulating substances, characterized in that apoptosis-specific markers released from a cell culture sample into an extracellular cell culture medium through cellular release is mechanisms are determined. The invention also concerns the use of an apoptosis detection kit for determining extracellular apoptosis-specific markers. It further relates to the use of cytochrome c and/or peptides derived thereof as a medicament, pharmaceutical compositions comprising cytochrome c and/or peptides derived thereof, and optionally a pharmaceutically acceptable carrier, and the use of cytochrome c and/or peptides derived thereof, for the preparation of a medicament for the treatment of diseases with inflammatory manifestation.
机译:公开了一种通过确定至少一种经历细胞凋亡的细胞通过细胞释放机制释放的细胞凋亡特异性标记物的存在,数量或活性来检测细胞凋亡的方法。细胞外培养基包括体液,特别是尿液,炎性液体,血清,液体或细胞培养基,其中样品优选取自人或动物。该方法可以用于与增加的细胞凋亡相关的疾病和/或过程的诊断和/或治疗控制。它也可以用于控制与凋亡减少有关的疾病的治疗。另外,公开了一种鉴定凋亡调节物质的方法,其特征在于确定了通过细胞释放从细胞培养样品释放到细胞外细胞培养基中的凋亡特异性标记。本发明还涉及凋亡检测试剂盒在确定细胞外凋亡特异性标志物中的用途。本发明还涉及细胞色素c和/或其衍生的肽作为药物的用途,包含细胞色素c和/或其衍生的肽以及任选的药学上可接受的载体的药物组合物,以及细胞色素c和/或其衍生的肽的用途。 ,用于制备用于治疗具有炎症表现的疾病的药物。

著录项

  • 公开/公告号DE60115453D1

    专利类型

  • 公开/公告日2006-01-05

    原文格式PDF

  • 申请/专利权人 EVOTEC AG;

    申请/专利号DE2001615453T

  • 申请日2001-07-20

  • 分类号A61K38/00;C07K14/47;C07K14/80;C12N9/04;G01N33/50;G01N33/573;G01N33/68;

  • 国家 DE

  • 入库时间 2022-08-21 21:18:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号